An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Clinical trial NCT06129240 · RECRUITING

Trial details

NCT number: NCT06129240
Sponsor: Liquidia Technologies, Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Pulmonary Hypertension Interstitial Lung Disease

Start date: 2023-12-28
Primary completion: 2027-07-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.